SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form C-AR - Annual Report:
SEC Accession No. 0001104659-22-054006
Filing Date
2022-05-02
Accepted
2022-05-02 06:14:27
Documents
2
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C-AR  
1 primary_doc.xml C-AR 4938
2 ANNUAL REPORT annual_report.pdf EX-99 604457
  Complete submission text file 0001104659-22-054006.txt   838880
Mailing Address 505 IRVING AVENUE SUITE 3100 A-B SYRACUSE NY 13210
Business Address 505 IRVING AVENUE SUITE 3100 A-B SYRACUSE NY 13210 607-227-4400
Quadrant Biosciences Inc (Filer) CIK: 0001651239 (see all company filings)

IRS No.: 473417864 | State of Incorp.: DE | Fiscal Year End: 1231
Type: C-AR | Act: 33 | File No.: 020-26816 | Film No.: 22879261
SIC: 2834 Pharmaceutical Preparations